Encompass Health Co. (NYSE:EHC) Shares Purchased by Algert Global LLC

Algert Global LLC lifted its position in Encompass Health Co. (NYSE:EHC) by 89.5% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 150,570 shares of the company’s stock after acquiring an additional 71,132 shares during the quarter. Encompass Health accounts for approximately 0.4% of Algert Global LLC’s holdings, making the stock its 23rd largest position. Algert Global LLC owned 0.15% of Encompass Health worth $14,551,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the company. Magnetar Financial LLC raised its position in shares of Encompass Health by 1,176.6% during the 2nd quarter. Magnetar Financial LLC now owns 744,836 shares of the company’s stock worth $63,899,000 after purchasing an additional 814,018 shares during the period. Thrivent Financial for Lutherans grew its stake in Encompass Health by 2,302.7% during the 2nd quarter. Thrivent Financial for Lutherans now owns 603,558 shares of the company’s stock worth $51,780,000 after buying an additional 578,438 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its stake in Encompass Health by 614.8% in the first quarter. Price T Rowe Associates Inc. MD now owns 540,519 shares of the company’s stock valued at $44,637,000 after buying an additional 464,897 shares during the last quarter. 8 Knots Management LLC boosted its holdings in shares of Encompass Health by 14.0% during the first quarter. 8 Knots Management LLC now owns 1,288,815 shares of the company’s stock valued at $106,430,000 after acquiring an additional 158,356 shares during the period. Finally, AQR Capital Management LLC grew its position in shares of Encompass Health by 213.3% during the second quarter. AQR Capital Management LLC now owns 207,202 shares of the company’s stock worth $17,776,000 after acquiring an additional 141,075 shares during the last quarter. 97.25% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several analysts recently weighed in on EHC shares. Truist Financial reiterated a “buy” rating and issued a $116.00 price objective (up from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Barclays boosted their price objective on Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. Royal Bank of Canada raised their target price on Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. Stephens reiterated an “overweight” rating and set a $105.00 price target on shares of Encompass Health in a research report on Tuesday, August 6th. Finally, KeyCorp increased their price target on Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. Nine equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $107.11.

Encompass Health Trading Up 1.8 %

Shares of Encompass Health stock opened at $101.14 on Friday. The business has a fifty day simple moving average of $97.11 and a 200-day simple moving average of $90.81. Encompass Health Co. has a fifty-two week low of $63.78 and a fifty-two week high of $104.55. The firm has a market cap of $10.19 billion, a price-to-earnings ratio of 24.43, a price-to-earnings-growth ratio of 1.32 and a beta of 0.88. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88.

Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, beating analysts’ consensus estimates of $0.94 by $0.09. The company had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.33 billion. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. Encompass Health’s revenue was up 11.9% on a year-over-year basis. During the same period in the prior year, the company earned $0.86 EPS. On average, equities analysts forecast that Encompass Health Co. will post 4.29 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be given a $0.17 dividend. The ex-dividend date of this dividend is Thursday, January 2nd. This represents a $0.68 annualized dividend and a yield of 0.67%. Encompass Health’s dividend payout ratio (DPR) is 16.43%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.